# Program 1 Evidence Index Track Phase C - Decision Evidence and Non-Approval Cross-Reference Register

Status: documentation-only, synthetic-only, non-production, non-runtime, decision-evidence indexing only.

## Purpose

Program 1 Evidence Index Track Phase C cross-references Program 1 decisions and non-approval records across the governance/prototype sequence, Architecture Review Track, post-closure verification record, Evidence Index Track Phase A, and Evidence Index Track Phase B.

Phase C follows Evidence Index Track Phase B. It is not an Implementation Proposal Track, not an implementation authorization, not a production-readiness review, not a clinical deployment review, not a go-live review, and not a blocker resolution phase.

## Scope

Phase C indexes:

- decision evidence
- non-approval records
- renewed hold decisions
- deferred capability decisions
- non-escalation decisions
- decision evidence limitations

## Non-Scope

Phase C does not resolve blockers, satisfy blockers, propose implementation, authorize implementation, add runtime behavior, add tests, add helpers, add scripts, create integrations, create connectors, create APIs, create deployment automation, create CI/CD, create infrastructure, process real data, process PHI/PII, create clinical behavior, create patient messaging, create appointment mutation, create workflow enforcement, create Task engine behavior, create Outcome Evidence behavior, create clinical write workflows, create approval/clearance/override capability, claim production readiness, or authorize go-live.

## Phase A/B Input Summary

Phase A inventoried governance/prototype, architecture review, and post-closure documentary evidence. Phase B mapped unresolved blockers to evidence sources and confirmed that traceability does not resolve blockers.

## Decision Evidence Summary

| Decision area | Evidence source families | Current decision |
| --- | --- | --- |
| Pre-implementation hold | Phase Z, Architecture Phase J, post-closure hold confirmation, Evidence Index Phases A-B | hold remains active |
| Production non-approval | Phases L, X, Y, Z, Architecture Phase J, post-closure non-approval | production not approved |
| Real-data non-approval | Phase O, Phase V, Architecture Phase G, Evidence Index Phases A-B | real patient data not approved |
| PHI/PII non-approval | Phase O, Architecture Phase G, post-closure non-approval | PHI/PII processing not approved |
| Implementation non-authorization | Phase Z, Architecture Phase J, post-closure verification, Evidence Index Phases A-B | implementation not authorized |
| Blocker non-resolution | Phase Y, Phase Z, Architecture Phase J, Evidence Index Phase B | blockers remain unresolved |

## Current Decision

Program 1 remains in renewed pre-implementation hold. Phase C provides cross-reference indexing only and does not authorize any implementation, runtime capability, clinical use, real-data use, PHI/PII processing, production readiness, or go-live.
